Opportunity ID: 73753

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH11-1145
Funding Opportunity Title: Improving Access to Laboratory Testing for HIV/AIDS Patient Monitoring in the Republic of Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Feb 24, 2011
Last Updated Date: Apr 20, 2011
Original Closing Date for Applications: Apr 21, 2011
Current Closing Date for Applications: Apr 21, 2011
Archive Date: May 21, 2011
Estimated Total Program Funding: $10,000,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
City or township governments
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
For profit organizations other than small businesses
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Additional Information on Eligibility: Eligible applicants that can apply for this funding opportunity are:
� Nonprofit with 501C3 IRS status (other than institution of higher education)
� Nonprofit without 501C3 IRS status (other than institution of higher education)
� For-profit organizations (other than small business)
� Small, minority, and women-owned businesses
� Universities
� Colleges
� Research institutions
� Hospitals
� Community-based organizations
� Faith-based organizations
� Federally recognized or state-recognized American Indian/Alaska Native tribal governments
� State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau)
� Non-domestic (non-U.S.) entity
� Other (specify)
A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with �Other Attachment Forms� when submitting via www.grants.gov.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this program is to support the HIV/AIDS national strategy and plan through the strengthening of laboratory services for implementation of the National Antiretroviral Therapy (ART) guidelines, in line with WHO ART recommendations, and improving the quality of care provided to HIV/AIDS patients. This is achieved through:� Increasing access to CD4 testing for HIV positive patients to support the roll out of the ART program according to the new WHO guidelines.� Increasing access to lab monitoring of patients on ART for early identification of treatment failure.� Providing access to other laboratory tests essential to monitoring the health of people living with HIV/AIDS and the side effects of ART.� Facilitating access to opportunistic infection diagnosis through establishment of a referral network from district hospitals and rural clinics to provincial labs with more advanced testing capacity.
Link to Additional Information: This is not an active link. Please click on the words “Full Announcement” at the top of this page.
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone 770-488-2602
Email:pgotim@cdc.gov

Version History

Version Modification Description Updated Date
Additional guidance provided in full announcement document. Apr 20, 2011
Apr 20, 2011

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH11-1145
Funding Opportunity Title: Improving Access to Laboratory Testing for HIV/AIDS Patient Monitoring in the Republic of Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Feb 24, 2011
Last Updated Date: Apr 20, 2011
Original Closing Date for Applications: Apr 21, 2011
Current Closing Date for Applications: Apr 21, 2011
Archive Date: May 21, 2011
Estimated Total Program Funding: $10,000,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
City or township governments
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
For profit organizations other than small businesses
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Additional Information on Eligibility: Eligible applicants that can apply for this funding opportunity are:
� Nonprofit with 501C3 IRS status (other than institution of higher education)
� Nonprofit without 501C3 IRS status (other than institution of higher education)
� For-profit organizations (other than small business)
� Small, minority, and women-owned businesses
� Universities
� Colleges
� Research institutions
� Hospitals
� Community-based organizations
� Faith-based organizations
� Federally recognized or state-recognized American Indian/Alaska Native tribal governments
� State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau)
� Non-domestic (non-U.S.) entity
� Other (specify)
A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with �Other Attachment Forms� when submitting via www.grants.gov.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this program is to support the HIV/AIDS national strategy and plan through the strengthening of laboratory services for implementation of the National Antiretroviral Therapy (ART) guidelines, in line with WHO ART recommendations, and improving the quality of care provided to HIV/AIDS patients. This is achieved through:� Increasing access to CD4 testing for HIV positive patients to support the roll out of the ART program according to the new WHO guidelines.� Increasing access to lab monitoring of patients on ART for early identification of treatment failure.� Providing access to other laboratory tests essential to monitoring the health of people living with HIV/AIDS and the side effects of ART.� Facilitating access to opportunistic infection diagnosis through establishment of a referral network from district hospitals and rural clinics to provincial labs with more advanced testing capacity.
Link to Additional Information: This is not an active link. Please click on the words “Full Announcement” at the top of this page.
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone 770-488-2602
Email:pgotim@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH11-1145
Funding Opportunity Title: Improving Access to Laboratory Testing for HIV/AIDS Patient Monitoring in the Republic of Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 20, 2011
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 21, 2011
Archive Date: May 21, 2011
Estimated Total Program Funding: $10,000,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Special district governments
State governments
Small businesses
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Additional Information on Eligibility: Eligible applicants that can apply for this funding opportunity are:
• Nonprofit with 501C3 IRS status (other than institution of higher education)
• Nonprofit without 501C3 IRS status (other than institution of higher education)
• For-profit organizations (other than small business)
• Small, minority, and women-owned businesses
• Universities
• Colleges
• Research institutions
• Hospitals
• Community-based organizations
• Faith-based organizations
• Federally recognized or state-recognized American Indian/Alaska Native tribal governments
• State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau)
• Non-domestic (non-U.S.) entity
• Other (specify)
A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with “Other Attachment Forms” when submitting via www.grants.gov.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of this program is to support the HIV/AIDS national strategy and plan through the strengthening of laboratory services for implementation of the National Antiretroviral Therapy (ART) guidelines, in line with WHO ART recommendations, and improving the quality of care provided to HIV/AIDS patients. This is achieved through:
• Increasing access to CD4 testing for HIV positive patients to support the roll out of the ART program according to the new WHO guidelines.
• Increasing access to lab monitoring of patients on ART for early identification of treatment failure.
• Providing access to other laboratory tests essential to monitoring the health of people living with HIV/AIDS and the side effects of ART.
• Facilitating access to opportunistic infection diagnosis through establishment of a referral network from district hospitals and rural clinics to provincial labs with more advanced testing capacity.
Link to Additional Information: This is not an active link. Please click on the words “Full Announcement” at the top of this page.
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone 770-488-2602
Email:pgotim@cdc.gov

Folder 73753 Full Announcement-1 -> gh11-1145 final amend i 04.20.11.pdf

Packages

Agency Contact Information: CDC
Procurement and Grants Office (PGO)
Technical Information Management Section (TIMS)
Phone 770-488-2602
Email: pgotim@cdc.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.067 CGH-GAP-NR CGH-GAP-NR PKG00035810 Feb 24, 2011 Apr 21, 2011 View

Package 1

Mandatory forms

73753 SF424-2.0.pdf

73753 SF424A-1.0.pdf

73753 HHS_CheckList-1.1.pdf

73753 Project-1.1.pdf

73753 Budget-1.1.pdf

Optional forms

73753 Other-1.1.pdf

2025-07-12T15:23:54-05:00

Share This Post, Choose Your Platform!

About the Author: